Angiotensin II type 1 receptor blockade prevents decrease in adult stem-like cells in kidney after ureteral obstruction.

Abstract

Infusion of renal side population (SP) cells, enriched with adult stem-like cells, can ameliorate acute renal failure. We investigated the effects of an angiotensin II type 1 (AT(1)) receptor antagonist, valsartan on SP cell changes in renal injury by ureteral obstruction. Renal SP fraction was reduced by 38%, and the number of cells expressing CD45, a marker of hematopoietic system, in renal SP cells was increased in obstructed kidneys. Valsartan attenuated renal injury and the associated SP profile changes. Angiotensin AT(1) receptor blockade may exert regenerative effect by preserving adult stem-like cells such as SP cells in the kidney.

• Authors: Takeshi Marumo, Keiichi Hishikawa, Yumi Matsuzaki, Naohiko Imai, Osamu Takase, Tatsuo Shimosawa, Hideyuki Okano, Toshiro Fujita
• Journal: European journal of pharmacology (Eur J Pharmacol) Vol. 573 Issue 1-3 Pg. 216-20 (Nov 14 2007) ISSN: 0014-2999 [Print] Netherlands
• PMID: 17692840 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Angiotensin II Type 1 Receptor Blockers
• Tetrazoles
• Valsartan
• Leukocyte Common Antigens
• Valine

Topics

• Angiotensin II Type 1 Receptor Blockers (administration & dosage, pharmacology)
• Animals
• Female
• Fibrosis
• Flow Cytometry
• Injections, Intraperitoneal
• Kidney (drug effects, metabolism, pathology)
• Leukocyte Common Antigens (biosynthesis)
• Mice
• Mice, Inbred C57BL
• Stem Cells (drug effects, metabolism, pathology)
• Tetrazoles (administration & dosage, pharmacology)
• Ureteral Obstruction (physiopathology)
• Valine (administration & dosage, analogs & derivatives, pharmacology)
• Valsartan